Hyperoside ameliorates diabetic nephropathy induced by STZ via targeting the miR-499–5p/APC axis
Diabetic nephropathy is a serious complication of diabetes. Hyperoside has been widely reported to ameliorate diabetes-associated disease. The current study is designed to explore the mechanism of hyperoside in diabetic nephropathy. In the present study, high glucose was used to treat podocytes. Dia...
שמור ב:
| Principais autores: | , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Elsevier
2021-05-01
|
| סדרה: | Journal of Pharmacological Sciences |
| נושאים: | |
| גישה מקוונת: | http://www.sciencedirect.com/science/article/pii/S1347861321000177 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|